150 related articles for article (PubMed ID: 15970430)
21. Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways.
Ip WK; Wong CK; Lam CW
Clin Exp Immunol; 2006 Jul; 145(1):162-72. PubMed ID: 16792687
[TBL] [Abstract][Full Text] [Related]
22. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
[TBL] [Abstract][Full Text] [Related]
23. Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines.
Barton BE; Karras JG; Murphy TF; Barton A; Huang HF
Mol Cancer Ther; 2004 Jan; 3(1):11-20. PubMed ID: 14749471
[TBL] [Abstract][Full Text] [Related]
24. Distinct regions of the granulocyte colony-stimulating factor receptor are required for tyrosine phosphorylation of the signaling molecules JAK2, Stat3, and p42, p44MAPK.
Nicholson SE; Novak U; Ziegler SF; Layton JE
Blood; 1995 Nov; 86(10):3698-704. PubMed ID: 7579336
[TBL] [Abstract][Full Text] [Related]
25. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action.
Suttles J; Milhorn DM; Miller RW; Poe JC; Wahl LM; Stout RD
J Biol Chem; 1999 Feb; 274(9):5835-42. PubMed ID: 10026206
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.
Bose C; Udupa KB
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C394-405. PubMed ID: 18550701
[TBL] [Abstract][Full Text] [Related]
27. Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells.
Carón RW; Yacoub A; Mitchell C; Zhu X; Hong Y; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P
Cell Cycle; 2005 Mar; 4(3):456-64. PubMed ID: 15655348
[TBL] [Abstract][Full Text] [Related]
28. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
29. Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism.
Lo RK; Cheung H; Wong YH
J Biol Chem; 2003 Dec; 278(52):52154-65. PubMed ID: 14551213
[TBL] [Abstract][Full Text] [Related]
30. Arginine-vasopressin activates the JAK-STAT pathway in vascular smooth muscle cells.
Levy O; Granot Y
J Biol Chem; 2006 Jun; 281(23):15597-604. PubMed ID: 16567810
[TBL] [Abstract][Full Text] [Related]
31. STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells.
Arany I; Megyesi JK; Nelkin BD; Safirstein RL
Kidney Int; 2006 Aug; 70(4):669-74. PubMed ID: 16788692
[TBL] [Abstract][Full Text] [Related]
32. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
33. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
Leventaki V; Drakos E; Medeiros LJ; Lim MS; Elenitoba-Johnson KS; Claret FX; Rassidakis GZ
Blood; 2007 Sep; 110(5):1621-30. PubMed ID: 17416736
[TBL] [Abstract][Full Text] [Related]
34. Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis.
Sellers LA; Simon J; Lundahl TS; Cousens DJ; Humphrey PP; Barnard EA
J Biol Chem; 2001 May; 276(19):16379-90. PubMed ID: 11278310
[TBL] [Abstract][Full Text] [Related]
35. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
[TBL] [Abstract][Full Text] [Related]
36. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
[TBL] [Abstract][Full Text] [Related]
37. A sensitive flow cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells.
Rouget R; Auclair Y; Loignon M; Affar el B; Drobetsky EA
J Biol Chem; 2008 Feb; 283(9):5533-41. PubMed ID: 18093981
[TBL] [Abstract][Full Text] [Related]
38. Histamine induces human beta-defensin-3 production in human keratinocytes.
Ishikawa T; Kanda N; Hau CS; Tada Y; Watanabe S
J Dermatol Sci; 2009 Nov; 56(2):121-7. PubMed ID: 19734018
[TBL] [Abstract][Full Text] [Related]
39. Role of ERK-BIM and STAT3-survivin signaling pathways in ALK inhibitor-induced apoptosis in EML4-ALK-positive lung cancer.
Takezawa K; Okamoto I; Nishio K; Jänne PA; Nakagawa K
Clin Cancer Res; 2011 Apr; 17(8):2140-8. PubMed ID: 21415216
[TBL] [Abstract][Full Text] [Related]
40. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
